Status:
RECRUITING
Combating Alzheimer's Through Sleep and Exercise
Lead Sponsor:
University of Miami
Collaborating Sponsors:
Shipley Foundation
Dreem
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
The purpose of this research is to see how sleep and exercise affects dementia risk over time.
Eligibility Criteria
Inclusion
- Able to perform mild exercise
- Able to wear DREEM 2 Headband
- Able to wear a Fitbit wrist watch
- Able to perform the Everlywell biomarker procedure
- Able to Understand and Speak English
- Able to operate a digital device like mobile phone, iPad, or computer
- Self-reported history of problems with cognitive impairment: memory, concentration, and processing information
- Only participants cognitively able and willing to provide consent will be included.
Exclusion
- Prohibited from or unable to perform mild exercise
- Unable to wear wrist watch or headband devices, or unable to supply pinprick blood sample for any reason
- Unable to speak or understand English
- Unable to use mobile device/smartphone technology
- Unable or unwilling to consent for any reason.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04855630
Start Date
March 1 2023
End Date
March 1 2026
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami Hospitals
Miami, Florida, United States, 33136